Pharmacokinetics and Tolerability of Duloxetine following Oral Administration to Healthy Chinese Subjects

被引：0
|
作者：
Si Tianmei
Mary Pat Knadler
Ming T. Lim
Kwee Poo Yeo
Leyan Teng
Shu Liang
Alan X. Pan
Evelyn D. Lobo
机构：
[1] Peking University Institute of Mental Health,Drug Disposition
[2] Eli Lilly and Company,Lilly
[3] Natlonal University of Singapore,NUS Centre for Clinical Pharmacology
[4] Global Pharmacokinetic/Pharmacodynamic/Trial Simulation,Eli Lilly and Company, Drug Disposition
来源：
Clinical Pharmacokinetics | 2007年 / 46卷
关键词：
Multiple Dose; Duloxetine; CYP1A2 Activity; Intermediate Metabolisers; Japanese Subject;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：767 / 775
页数：8
相关论文
共 50 条
  • [31] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Yue-Qi Li
    Zheng-Yu Yan
    Hong-Wen Zhang
    Lu-Ning Sun
    Hui-Wen Jiao
    Mei-Feng Wang
    Li-Yuan Yu
    Lei Yu
    Zi-Qing-Yun Yuan
    Ling Meng
    Yong-Qing Wang
    European Journal of Clinical Pharmacology, 2017, 73 : 547 - 554
  • [32] A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Semaglutide in Healthy Chinese Subjects
    Shi, Aixin
    Xie, Panpan
    Nielsen, Lasse L.
    Skjoeth, Trine V.
    He, Xuemei
    Haugaard, Sine P.
    DIABETES, 2020, 69
  • [33] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Li, Yue-Qi
    Yan, Zheng-Yu
    Zhang, Hong-Wen
    Sun, Lu-Ning
    Jiao, Hui-Wen
    Wang, Mei-Feng
    Yu, Li-Yuan
    Yu, Lei
    Yuan, Zi-Qing-Yun
    Meng, Ling
    Wang, Yong-Qing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 547 - 554
  • [34] Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers
    Xiao, Y.
    Lu, Y.
    Kang, Z.
    Hou, F.
    Wang, S.
    Li, T.
    Liu, Y.
    Xia, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (04) : 172 - 179
  • [35] Pharmacokinetics of Bismuth following Oral Administration of Wei Bi Mei in Healthy Chinese Volunteers
    Zhang, Lingye
    Liu, Juan
    Meng, Fandong
    Guan, Yingying
    Wang, Yongjun
    Zhu, Shengtao
    Liu, Yaqiong
    Xie, Qing
    Yu, Junxian
    Zhang, Shutian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [36] Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects
    Volosov, A
    Sun, XD
    Perucca, E
    Yagen, B
    Sintov, A
    Perucca, E
    Yagen, B
    Sintov, A
    Bialer, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (06) : 547 - 553
  • [37] Pharmacokinetics of Acamprosate Calcium in Healthy Chinese Subjects after Oral Administration of Three Dosage Levels
    Xu, Fan
    Qing, Yongping
    Shang, Beicheng
    Liang, Maozhi
    Zou, Yuangao
    Xu, Guili
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (12): : 631 - 634
  • [38] Pharmacokinetics and tolerability of probucol after multiple oral administration in healthy volunteers
    Jeon, H.
    Lee, S.
    Kim, T. -E.
    Yoon, S. H.
    Shin, S. -G.
    Jang, I. -J.
    Yu, K. -S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (11) : 688 - 694
  • [39] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VALBENAZINE AFTER SINGLE AND MULTIPLE ORAL ADMINISTRATION IN HEALTHY KOREAN MALE SUBJECTS.
    Chung, W.
    Huh, K.
    Ka, J.
    Bae, S.
    Oh, J.
    Yoon, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S15 - S15
  • [40] Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
    Johnson, Theodore R.
    Tan, Weiwei
    Goulet, Lance
    Smith, Evan B.
    Yamazaki, Shinji
    Walker, Gregory S.
    O'Gorman, Melissa T.
    Bedarida, Gabriella
    Zou, Helen Y.
    Christensen, James G.
    Nguyen, Leslie N.
    Shen, Zhongzhou
    Dalvie, Deepak
    Bello, Akintunde
    Smith, Bill J.
    XENOBIOTICA, 2015, 45 (01) : 45 - 59
12345